Результаты поиска

Fractal Dimension Analysis of Mandibular Trabecular Bone in Patients Receiving Antiresorptive Therapy for Osteoporosis and Oncologic Conditions.

Objectives: This study aimed to assess the effects of antiresorptive drugs on mandibular trabecular bone structure in patients with osteoporosis and those receiving antiresorptive therapy for oncologic conditions using fractal dimension (FD) analysis of panoramic radiographs. Additionally, it investigated the influences of age, gender, drug type, administration route, and treatment duration on mandibular trabecular bone structure. Methods: This retrospective cross-sectional study included 73 patients categorized into the following three groups: 23 osteoporosis patients, 25 oncologic patients,

Efficacy of expressive helping in adult hematologic cancer patients undergoing stem cell transplant: protocol for the Writing for Insight, Strength, and Ease (WISE) study's two-arm randomized controlled trial.

BackgroundDuring, shortly after, and sometimes for years after hematopoietic stem cell transplant, a large proportion of hematological cancer patients undergoing transplant report significant physical and psychological symptoms and reduced health-related quality of life. To address these survivorship problems, we developed a low-burden, brief psychological intervention called expressive helping that includes two theory- and evidence-based components designed to work together synergistically: emotionally expressive writing and peer support writing. Building on evidence from a prior randomized c

:: < < Действенность и безопасность антителных препаратов > > (BCMA) в программе < < Развитие против рака: систематический обзор > > .

В качестве перспективных методов лечения повторной/охлажденной множественной миеломы (RRMM) появились антителные антигены (BCMA), ориентированные на антитела-наркотики (ADC). Цель этого исследования заключалась в обобщении имеющихся данных о безопасности и эффективности БКМА-АДЦ в процессе разработки системы RRM.MetodsA систематического поиска. six Библиографические базы данных и клинические анализы.gov до ноября 2024. Исследования имеют право на проведение таких исследований, если они являются клиническими испытаниями человека или исследованиями животных с оценкой БЦМА-АЦД, и если они содержа

Каннабиноиды: терапевтические перспективы для борьбы с орофасиальной болью, оральное воспаление и систематическое обследование на предмет вылечения костей.

Каннабиноиды, в частности каннабидиол (КБР) и тетрагидроканнабинол (THC), все чаще изучаются на предмет их терапевтического применения в различных медицинских областях. Целью этого систематического обзора является изучение их роли в оральной хирургии с уделением особого внимания обезболиванию, воспалению и регенерации костей. Систематический обзор был проведен с использованием системы PRISMA для выявления соответствующих исследований из баз данных PubMed, Scopus и Web-сайта науки, опубликованных до ноября 2024. Обзор включал в себя клинические и предклинические исследования, посвященные изучен

Interplay between mobility, social participation, and symptom burden in advanced lung cancer

PURPOSE: Advanced non-small cell lung cancer (NSCLC) is associated with a high symptom burden that negatively impacts daily functioning and quality of life. A better understanding of the time course and relationships between these constructs can help tailor rehabilitation interventions in the context of disease progression. The objectives were to describe and compare the trajectories in mobility, participation, and symptom burden and to assess associations and explore predictors of mobility change. METHODS: Secondary data analysis of a longitudinal cohort study of 110 participants with NSCLC.

Совпадение в полном тексте источника
… A 10-point change in the global disability score, corresponding to a 10% minimal clinically important difference (MCID), highlights meaningful mobility changes in participants with high symptom burden [ 31 ]. … M, Barrett J, Bellomo R, Cooper DJ et al (2021) The psychometric properties and minimal clinically important difference for disability assessment using WHODAS 2.0 in critically ill patients. …

Поощрение использования продольных электронных медицинских записей: обучение по изучению реальных мировых данных о последствиях хронических заболеваний.

Для борьбы с хроническими заболеваниями требуется постоянный мониторинг деятельности по борьбе с заболеваниями и терапевтическое реагирование в целях оптимизации планов лечения. С учетом растущей доступности методов лечения, позволяющих сглаживать заболевания, крайне важно изучить вопрос о сравнительной эффективности и долгосрочных результатах, помимо тех, которые могут быть получены в ходе выборочных клинических испытаний. Мы внедряем всеобъемлющий трубопровод для получения воспроизводимых и обобщенных реальных данных о результатах болезней за счет использования электронных данных о состоянии

Study of a novel Ca/P/S-based cement implanted in the osteoporotic goat spine and its clinical application in preventing adjacent vertebral fractures.

Osteoporotic vertebral compression fracture (OVCF) has been increasing over the last decades. In addition to primary OVCF, the adjacent vertebral fracture (AVF) is a frequent serious complication in OVCF patients receiving percutaneous vertebroplasty or kyphoplasty, resulting in poor long-term outcome and recurrent symptoms. The aim of the present study is to investigate the bone regeneration behavior of a novel Ca/P/S-based resorbable cement (Ezechbone® Cement CBC-400) implanted into surgically created vertebral defects of ovariectomized (OVX) goats. Furthermore, the present study provides a

Химерический антигенный рецептор T-клеточная терапия в нейроиммунных болезнях: механистическое обоснование, клинический опыт и проблемы с переводом.

Нейроиммунные заболевания представляют собой разнородную группу расстройств, при которых клетки В, плазменные удары, плазменные клетки, автоантитела и Т клетки поразному влияют на повреждение тканей. Хотя биологика B-клеток улучшила контроль за заболеваниями, некоторые пациенты по-прежнему сталкиваются с реанимацией, рецидивом после лечения или кумулятивной неврологической инвалидностью. Химерическая антигенная рецепторная T-клетка (CAR-T-клетка) является средством достижения более глубокого и потенциально устойчивого истощения определенных патогенных иммунных клеток. Этот описательный обзор в

Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committe.

Since the World has been facing the COVID-19 pandemic, special attention has been taken concerning cancer patients; related to their immunosuppression status, adding risk for more aggressive COVID-19 and mortality, but also concerns about the access and the quality of care in cancer therapy. The COVID-19 pandemic impacts the number of infected, its related mortality, as well as the care of cancer patients. Multiple myeloma patients are a particular group with several important aspects to be considered during pandemic times. In essence, they are immunosuppressed in different intensities during

Development and validation of a multiparametric MRI-based radiomics nomogram for the tripartite discrimination of primary benign, primary malignant, and metastatic lumbar spinal tumors.

ObjectiveTo develop and validate a multiparametric magnetic resonance imaging-based radiomics nomogram for the non-invasive preoperative differentiation of primary benign, primary malignant, and metastatic lumbar spinal tumors.MethodologyThis retrospective study enrolled 100 patients with pathologically confirmed lumbar tumors. Radiomics features were extracted from T1-weighted, T2-weighted, and fat-suppressed T2-weighted sequences. A radiomics signature was constructed using a two-step feature selection method comprising minimum redundancy maximum relevance and least absolute shrinkage and se

Sestrin-2: a new biomarker for type 2 Diabetes Mellitus and Insulin resistance.

Multiple myeloma (MM) is the second most common haematological malignancy characterised by clonal proliferation of plasma cells within the bone marrow. Despite advances in treatment options, myeloma remains incurable. Relapsed MM poses significant challenges due to clonal evolution, drug resistance, patient comorbidities and therefore complexities of therapeutic decision-making. A critical question in managing relapsed MM is whether to switch drug classes or retreat with agents within the same class. The question is present with the recent addition of three new drug classes (XPO1 inhibitors, B

Hijacking the helpers: platelet and neutrophil trafficking in AML and therapeutic exploitation.

Acute myeloid leukemia (AML) remains one of the most aggressive and treatment-resistant hematologic malignancies, driven by clonal expansion of immature myeloid blasts in the bone marrow and peripheral blood. Current therapies-chemotherapy and targeted agents-are limited by poor marrow penetration, systemic toxicity, and rapid development of resistant clones, leaving long-term survival rates low. Clinicians face the persistent challenge of delivering effective therapy while minimizing harm. Platelets and neutrophils-beyond their classical roles in hemostasis and innate immunity-actively suppor

Feasibility of patient-reported outcomes collection in clinical routine at a radiotherapy department.

Background and purposeRoutine collection of patient-reported outcome measures (PROMs) may provide valuable real-world data on quality of life (QoL) and treatment tolerability, complementing clinical outcomes. This study evaluated the feasibility of launching a semi-automated, department-wide PROM collection program at a large tertiary radiotherapy centre.Patients and methodsPatients ≥ 18 years referred for radiotherapy were invited to participate. Exclusion criteria were inability to provide informed consent, severe cognitive conditions, or language barriers. PROMs were collected using a web-b

Cancer-Induced Cardiac Dysfunction: Mechanisms, Diagnostics, and Emerging Therapeutics in the Era of Onco-Cardiology.

Cancer-induced cardiac dysfunction has become a major clinical challenge as advances in cancer therapies continue to extend patient survival. Once regarded as a secondary concern, cardiotoxicity is now recognized as a leading contributor to morbidity and mortality among cancer patients and survivors. Its pathophysiology is multifactorial, involving systemic inflammation (e.g., TNF-α, IL-6), oxidative stress driven by reactive oxygen species (ROS), neurohormonal imbalances (e.g., angiotensin II, endothelin-1), and metabolic disturbances. These mechanisms collectively promote cardiomyocyte apopt

Treatment Inertia and Symptom Burden in Anemia of CKD: Insights from the SATISFY Survey in the Middle East, South Africa, and Türkiye.

IntroductionLimited data exist regarding treatment patterns and symptom burden of patients with anemia of chronic kidney disease (CKD) in the Middle East, South Africa, and Türkiye.MethodsThis real-world study explored clinical characteristics, symptom burden, and treatment patterns of patients with anemia of CKD living in the Middle East, South Africa, and Türkiye. Physician and patient perceptions of treatment were captured via cross-sectional surveys; patients' clinical characteristics were recorded by retrospective review of medical records.ResultsData were collected from 1788 patients and

Hematological Malignancy-Derived Small Extracellular Vesicles and Tumor Microenvironment: The Art of Turning Foes into Friends.

Small extracellular vesicles (small EVs) are commonly released by all cells, and are found in all body fluids. They are implicated in cell to cell short- and long-distance communication through the transfer of genetic material and proteins, as well as interactions between target cell membrane receptors and ligands anchored on small EV membrane. Beyond their canonical functions in healthy tissues, small EVs are strategically used by tumors to communicate with the cellular microenvironment and to establish a proper niche which would ultimately allow cancer cell proliferation, escape from the imm

Adoptive Immunotherapy and High-Risk Myeloma.

Despite significant improvements in the treatment of multiple myeloma (MM), it remains mostly incurable, highlighting a need for new therapeutic approaches. Patients with high-risk disease characteristics have a particularly poor prognosis and limited response to current frontline therapies. The recent development of immunotherapeutic strategies, particularly T cell-based agents have changed the treatment landscape for patients with relapsed and refractory disease. Adoptive cellular therapies include chimeric antigen receptor (CAR) T cells, which have emerged as a highly promising therapy, par

The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications Management.

The outcome of multiple myeloma (MM) has significantly improved in the last few decades due to several factors such as new biological discoveries allowing to better stratify disease risk, development of more effective therapies and better management of side effects related to them. However, handling all these aspects requires an interdisciplinary approach involving multiple knowledge and collaboration of different specialists. The hematologist, faced with a patient with MM, must not only choose a treatment according to patient and disease characteristics but must also know when therapy needs t

Stem Cells Collection and Mobilization in Adult Autologous/Allogeneic Transplantation: Critical Points and Future Challenges.

Achieving successful hematopoietic stem cell transplantation (HSCT) relies on two fundamental pillars: effective mobilization and efficient collection through apheresis to attain the optimal graft dose. These cornerstones pave the way for enhanced patient outcomes. The primary challenges encountered by the clinical unit and collection facility within a transplant program encompass augmenting mobilization efficiency to optimize the harvest of target cell populations, implementing robust monitoring and predictive strategies for mobilization, streamlining the apheresis procedure to minimize colle

Лучшие достижения года: Биотипные антитела на ранних линиях терапии в множестве миеломы.

После их введения в качестве терапии для сильного рефрактного множества миэломы, лица, занимающиеся диагностикой двух клеток, недавно получили исключительно глубокие и долговременные ответные реакции на ранние линии терапии, включая ранние данные о новых диагностированных болезнях. Сохраняется множество проблем, включая оптимальную обстановку и сочетание, смягчение токсичности и уточнение оптимальной продолжительности терапии.